All Stories
- Designing Nanosystems to Target Myc in Prostate Cancer
Article
- Green Synthesis of Mesquite-Gum-Stabilized Gold Nanoparticles for Biomedical Applications: Physicochemical Properties and Biocompatibility Assessment
Article
- Aptamer-Conjugated Gold Nanoparticles Targeting Human Epidermal Growth Factor Receptor 2 (HER2) for Cancer Theranostic, In Vitro Assays
Article
- pMyc and pMax Peptides Nanosystems and the Potential Treatment of Prostate Cancer, In Vitro Assays
Article
- Applications of cell-penetrating peptide nanosystems in breast and prostate cancer.
Article
- Modification of Branched Polyethyleneimine Using Mesquite Gum for Its Improved Hemocompatibility
Article
- A Full Set of In Vitro Assays in Chitosan/Tween 80 Microspheres Loaded with Magnetite Nanoparticles
Article
- Steroid 5 alpha-reductase 2 enzyme variants, biomass exposure and tobacco use in Mexican patients with prostate cancer
Article
- Association study in Mexican patients with thyrotoxic hypokalemic periodic paralysis
Article
- Associations of nicotidamide-N-methyltransferase, FTO, and IRX3 genetic variants with body mass index and resting energy expenditure in Mexican subjects
Article
- Whole exome sequencing identifies multiple novel candidate genes in familial gastroschisis
- Database for Gene Variants and Metabolic Networks Implicated in Familial Gastroschisis
Article
- Bioinformatic Analysis of Gene Variants from Gastroschisis Recurrence Identifies Multiple Novel Pathogenetic Pathways: Implication for the Closure of the Ventral Body Wall
Article
- MON-092 Role of Genetic Variants of NNMT rs694539 and rs1941404, FTO rs1421085 and Irx3 rs3751723 Polymorphisms on Resting Energy Expenditure and BMI
Article
- A clinical-pathogenetic approach on associated anomalies and chromosomal defects supports novel candidate critical regions and genes for gastroschisis
- Uridine 5'‑diphospho‑glucronosyltrasferase: Its role in pharmacogenomics and human disease (Review)
- Nanoparticles for death‑induced gene therapy in cancer (Review)
- Genetic variants in KCNJ11, TCF7L2 and HNF4A are associated with type 2 diabetes, BMI and dyslipidemia in families of Northeastern Mexico: A pilot study
- Candidate gene polymorphisms and risk of psoriasis: A pilot study
- A pharmacogenetic pilot study reveals MTHFR, DRD3, and MDR1 polymorphisms as biomarker candidates for slow atorvastatin metabolizers
- Assessment of biochemical parameters and characterization of TNFα −308G/A and PTPN22 +1858C/T gene polymorphisms in the risk of obesity in adolescents
- High prevalence of diabetic retinopathy and lack of association with integrin α2 gene polymorphisms in patients with type 2 diabetes from Northeastern Mexico
- Frequency of SMN1 deletion carriers in a Mestizo population of central and northeastern Mexico: A pilot study
Article
- Detection of Turner Syndrome by Quantitative PCR of SHOX and VAMP7 Genes
- An investigation into theMMP1gene promoter region polymorphism - 1607 2G with recessive dystrophic epidermolysis bullosa disease severity in northeastern Mexican patients
- The Tumor Necrosis Factor α (-308 A/G) Polymorphism Is Associated with Cystic Fibrosis in Mexican Patients
- Nanoparticles vs Cancer: A Multifuncional Tool
Article
- Genetic structure of Mexican Mestizos with type 2 diabetes mellitus based on three STR loci
